{"DataElement":{"publicId":"7125054","version":"1","preferredName":"Nasopharyngeal Cancer AJCC Edition 8 Group Stage","preferredDefinition":"Stage group based on the combination of T, N, and M categories and relevant prognostic factors for nasopharyngeal carcinoma, using AJCC Ed. 8 criteria.","longName":"NPC_AJC8_ DZ_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3914942","version":"1","preferredName":"Nasopharynx Tumor Stage Grouping","preferredDefinition":"The part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"2452490v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2452490","version":"1","preferredName":"Nasopharynx Neoplasm","preferredDefinition":"The nasal part of the pharynx, lying above the level of the soft palate.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12423:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharynx","conceptCode":"C12423","definition":"The part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-66FC-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-23","modifiedBy":"ONEDATA","dateModified":"2006-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E7ECED27-38E6-914F-E040-BB89AD436D0B","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"TAYLORT","dateModified":"2020-01-08","changeDescription":"1/8/20 tmt added Registration Status.; 1/8/20 tmt transferred ownership from NCIP to NCI Standards. Created per RTOG request for CRF standard harmonization. mc 10/4/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7125040","version":"1","preferredName":"Nasopharyngeal Carcinoma American Joint Committee on Cancer Edition 8 Group Stage","preferredDefinition":"A term that refers to the staging of nasopharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"7125040v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IVB","valueDescription":"Stage IVB Nasopharyngeal Carcinoma AJCC v8","ValueMeaning":{"publicId":"7125043","version":"1","preferredName":"Stage IVB Nasopharyngeal Carcinoma AJCC v8","longName":"7125043","preferredDefinition":"Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Nasopharyngeal Carcinoma AJCC v8","conceptCode":"C132822","definition":"Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BA1A37F-8E2D-592E-E053-F662850AE350","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BA1A37F-8E46-592E-E053-F662850AE350","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA Nasopharyngeal Carcinoma AJCC v8","ValueMeaning":{"publicId":"7125045","version":"1","preferredName":"Stage IVA Nasopharyngeal Carcinoma AJCC v8","longName":"7125045","preferredDefinition":"Stage IVA includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); (Any T, N3, M0); T4: Tumor with intracranial extension, involvement of cranial nerves, hypopharynx, orbit, parotid gland, and/or extensive soft tissue infiltration beyond the lateral surface of the lateral pterygoid muscle.  N0: No regional lymph node metastasis. N1: Tumor with unilateral metastasis in cervical lymph node(s), and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. N2: Tumor with bilateral metastasis in cervical lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. N3: Tumor with unilateral or bilateral metastasis in cervical lymph node(s), larger than 6 cm in greatest dimension, and/or extension below the caudal border of cricoid cartilage. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Nasopharyngeal Carcinoma AJCC v8","conceptCode":"C132821","definition":"Stage IVA includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); (Any T, N3, M0); T4: Tumor with intracranial extension, involvement of cranial nerves, hypopharynx, orbit, parotid gland, and/or extensive soft tissue infiltration beyond the lateral surface of the lateral pterygoid muscle.  N0: No regional lymph node metastasis. N1: Tumor with unilateral metastasis in cervical lymph node(s), and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. N2: Tumor with bilateral metastasis in cervical lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. N3: Tumor with unilateral or bilateral metastasis in cervical lymph node(s), larger than 6 cm in greatest dimension, and/or extension below the caudal border of cricoid cartilage. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BA1A37F-8E53-592E-E053-F662850AE350","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BA1A37F-8E6C-592E-E053-F662850AE350","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Nasopharyngeal Carcinoma AJCC v8","ValueMeaning":{"publicId":"7125047","version":"1","preferredName":"Stage III Nasopharyngeal Carcinoma AJCC v8","longName":"7125047","preferredDefinition":"Stage III includes: (T1, N2, M0); (T0, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T1: Tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal involvement. T0: No tumor identified, but EBV-positive cervical node(s) involvement is present. T2: Tumor with extension to parapharyngeal space, and/or adjacent soft tissue involvement (medial pterygoid, lateral pterygoid, prevertebral muscles). T3: Tumor infiltrating bony structures at skull base, cervical vertebrae, pterygoid structures, and/or paranasal sinuses. N0: No regional lymph node metastasis. N1: Tumor with unilateral metastasis in cervical lymph node(s), and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. N2: Tumor with bilateral metastasis in cervical lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Nasopharyngeal Carcinoma AJCC v8","conceptCode":"C132819","definition":"Stage III includes: (T1, N2, M0); (T0, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T1: Tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal involvement. T0: No tumor identified, but EBV-positive cervical node(s) involvement is present. T2: Tumor with extension to parapharyngeal space, and/or adjacent soft tissue involvement (medial pterygoid, lateral pterygoid, prevertebral muscles). T3: Tumor infiltrating bony structures at skull base, cervical vertebrae, pterygoid structures, and/or paranasal sinuses. N0: No regional lymph node metastasis. N1: Tumor with unilateral metastasis in cervical lymph node(s), and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. N2: Tumor with bilateral metastasis in cervical lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BA1A37F-8E79-592E-E053-F662850AE350","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BA1A37F-8E92-592E-E053-F662850AE350","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Nasopharyngeal Carcinoma AJCC v8","ValueMeaning":{"publicId":"7125049","version":"1","preferredName":"Stage II Nasopharyngeal Carcinoma AJCC v8","longName":"7125049","preferredDefinition":"Stage II includes: (T1, N1, M0); (T0, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal involvement. T0: No tumor identified, but EBV-positive cervical node(s) involvement is present. T2: Tumor with extension to parapharyngeal space, and/or adjacent soft tissue involvement (medial pterygoid, lateral pterygoid, prevertebral muscles). N0: No regional lymph node metastasis. N1: Tumor with unilateral metastasis in cervical lymph node(s), and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Nasopharyngeal Carcinoma AJCC v8","conceptCode":"C132818","definition":"Stage II includes: (T1, N1, M0); (T0, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal involvement. T0: No tumor identified, but EBV-positive cervical node(s) involvement is present. T2: Tumor with extension to parapharyngeal space, and/or adjacent soft tissue involvement (medial pterygoid, lateral pterygoid, prevertebral muscles). N0: No regional lymph node metastasis. N1: Tumor with unilateral metastasis in cervical lymph node(s), and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BA1A37F-8E9F-592E-E053-F662850AE350","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BA1A37F-8EB8-592E-E053-F662850AE350","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Nasopharyngeal Carcinoma AJCC v8","ValueMeaning":{"publicId":"7125051","version":"1","preferredName":"Stage I Nasopharyngeal Carcinoma AJCC v8","longName":"7125051","preferredDefinition":"Stage I includes: T1, N0, M0. T1: Tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal involvement. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Nasopharyngeal Carcinoma AJCC v8","conceptCode":"C132817","definition":"Stage I includes: T1, N0, M0. T1: Tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal involvement. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BA1A37F-8EC5-592E-E053-F662850AE350","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BA1A37F-8EDE-592E-E053-F662850AE350","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Nasopharyngeal Carcinoma","ValueMeaning":{"publicId":"3914936","version":"1","preferredName":"Stage 0 Nasopharyngeal Carcinoma","longName":"3914936","preferredDefinition":"Abnormal cells are found in the lining of the nasopharynx (the upper part of the throat behind the nose). These abnormal cells may become cancer and spread into nearby normal tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8","conceptCode":"C9099","definition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7ECED27-3865-914F-E040-BB89AD436D0B","latestVersionIndicator":"Yes","beginDate":"2013-10-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BA1A37F-8EE8-592E-E053-F662850AE350","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7125039","version":"1","preferredName":"Nasopharyngeal Carcinoma by AJCC v8 Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the staging of nasopharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C132816:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Carcinoma by AJCC v8 Stage","conceptCode":"C132816","definition":"A term that refers to the staging of nasopharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BA418ED-210E-75E0-E053-F662850AA3DB","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"9BA418ED-211F-75E0-E053-F662850AA3DB","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"TAYLORT","dateModified":"2020-01-09","changeDescription":"1/9/20 tmt released.; 1/8/20 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000588","version":"1","longName":"Nasopharyngeal","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease stage","type":"Preferred Question Text","description":"Disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"9BA1D9F6-847A-5936-E053-F662850A02EC","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-08","modifiedBy":"TAYLORT","dateModified":"2020-01-09","changeDescription":"1/9/20 tmt released.; 1/8/20 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}